Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-06-20 Purchase |
2023-06-20 9:58 pm |
Vivos Therapeutics Inc. | VVOS | Huntsman Ronald Kirk Chief Executive Officer |
14,000 | $0.53 | $7,420 | 1,826,521 (Indirect Direct) |
View |
| 2023-06-15 Purchase |
2023-06-20 06:10 am |
Vivos Therapeutics Inc. | VVOS | Huntsman Ronald Kirk Chief Executive Officer |
15,021 | $0.53662 | $8,061 | 1,812,521 (Indirect Direct) |
View |
| 2023-06-14 Purchase |
2023-06-15 7:15 pm |
Vivos Therapeutics Inc. | VVOS | Huntsman Ronald Kirk Chief Executive Officer |
10,000 | $0.49 | $4,900 | 1,797,500 (Indirect Direct) |
View |
| 2022-12-23 Purchase |
2022-12-28 9:45 pm |
Vivos Therapeutics Inc. | VVOS | Huntsman Ronald Kirk Chief Executive Officer 10% Owner |
20,000 | $0.5 | $10,000 | 2,604,168 (Indirect Direct) |
View |
| 2022-05-31 Purchase |
2022-06-03 06:08 am |
Vivos Therapeutics Inc. | VVOS | Huntsman Ronald Kirk Chief Executive Officer 10% Owner |
12,000 | $1.9633 | $23,560 | 1,767,500 (Indirect Direct) |
View |
| 2021-09-21 Purchase |
2021-09-22 3:09 pm |
Vivos Therapeutics Inc. | VVOS | Huntsman Ronald Kirk Chief Executive Officer |
5,000 | $4.31 | $21,550 | 2,088,834 (Indirect Direct) |
View |
| 2021-08-17 Purchase |
2021-08-18 3:47 pm |
Vivos Therapeutics Inc. | VVOS | Huntsman Ronald Kirk Chief Executive Officer |
5,000 | $3 | $15,000 | 2,083,834 (Indirect Direct) |
View |
| 2021-05-25 Purchase |
2021-05-25 9:45 pm |
Vivos Therapeutics Inc. | VVOS | Huntsman Ronald Kirk Chief Executive Officer |
4,000 | $5.38 | $21,520 | 2,087,834 (Indirect Direct) |
View |
| 2020-12-23 Purchase |
2020-12-23 6:53 pm |
Vivos Therapeutics Inc. | VVOS | Huntsman Ronald Kirk Chief Executive Officer 10% Owner |
1,000 | $7.2669 | $7,267 | 2,083,834 (Indirect Direct) |
View |
| 2020-12-11 Purchase |
2020-12-14 08:45 am |
Vivos Therapeutics Inc. | VVOS | Huntsman Ronald Kirk Chief Executive Officer 10% Owner |
500 | $8.5 | $4,250 | 2,082,834 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-11-26 Option Award |
2024-11-27 4:47 pm |
N/A 2034-09-07 |
Vivos Therapeutics Inc. | VVOS | Huntsman Ronald Kirk Chief Executive Officer |
315,421 | $2.64 | 437,816 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-28 8:53 pm |
N/A 2029-06-20 |
Vivos Therapeutics Inc. | VVOS | Huntsman Ronald Kirk Chief Executive Officer |
20,000 | $2.38 | 122,395 (Direct) |
View |
| 2022-12-23 Option Award |
2022-12-28 9:45 pm |
N/A 2027-12-23 |
Vivos Therapeutics Inc. | VVOS | Huntsman Ronald Kirk Chief Executive Officer 10% Owner |
483,334 | $0.48 | 2,604,168 (Direct) |
View |
| 2022-02-25 Option Award |
2022-02-28 6:54 pm |
N/A 2027-02-25 |
Vivos Therapeutics Inc. | VVOS | Huntsman Ronald Kirk Chief Executive Officer |
125,000 | $3.27 | 125,000 (Direct) |
View |
| 2021-06-16 Ownership |
2022-02-14 9:21 pm |
N/A 2026-06-26 |
Vivos Therapeutics Inc. | VVOS | Huntsman Ronald Kirk Chief Executive Officer |
125,000 | $5.64 | 125,000 (Direct) |
View |
Ownership(A) |
2021-06-29 4:18 pm |
N/A N/A |
Vivos Therapeutics Inc. | VVOS | Huntsman Ronald Kirk Chairman and CEO 10% Owner |
0 | $0 | 1,740,000 (Indirect) |
View |
Ownership |
2020-12-10 9:52 pm |
N/A N/A |
Vivos Therapeutics Inc. | VVOS | Huntsman Ronald Kirk Chairman & CEO 10% Owner |
0 | $0 | 2,082,334 (Indirect) |
View |